Effect of Antimicrobial Stewardship Interventions on Clinical Outcomes and Antimicrobial Resistance among Neonates with Sepsis in Selected Health Facilities in Kiambu County, Kenya

Authors

Amos Mureithi Njeru

School of Health Science, Great Lakes University of Kisumu, Kisumu County (Kenya)

Joseph Choge

School of Health Science, Great Lakes University of Kisumu, Kisumu County (Kenya)

Manaseh Bocha

School of Health Science, Great Lakes University of Kisumu, Kisumu County (Kenya)

Article Information

DOI: 10.51244/IJRSI.2026.1315PH00163

Subject Category: Public Health

Volume/Issue: 13/15 | Page No: 3421-3431

Publication Timeline

Submitted: 2026-08-20

Accepted: 2026-08-25

Published: 2026-09-01

Abstract

Background: Neonatal sepsis remains an important cause of neonatal morbidity and mortality, while inappropriate and prolonged antimicrobial use contributes to antimicrobial resistance and adverse drug events. Antimicrobial stewardship (AMS) interventions provide a strategy for optimizing antimicrobial selection, dosing, duration, and review while maintaining effective treatment of infection.
Methods: A quasi-experimental interrupted time-series design with a non-equivalent comparison group was used. The study involved neonates aged 0–28 days diagnosed with neonatal sepsis in selected Level 4 and Level 5 hospitals in Kiambu County. Intervention facilities implemented antimicrobial stewardship interventions comprising prescribing guidelines, audit and feedback, diagnostic stewardship, antimicrobial review, de-escalation, and healthcare-provider training, while comparison facilities continued routine care. Quantitative data were obtained through medical record review and healthcare-provider questionnaires, while qualitative information was collected through key informant interviews. Data were analyzed using SPSS version 30.0. Descriptive statistics, chi-square/Fisher's exact tests, Mann–Whitney U tests, segmented regression, and multivariable regression were used.
Results: Recovery was higher among neonates in the intervention group than the control group, 100 (93.5%) versus 82 (76.6%), while mortality was lower, 2 (1.9%) versus 9 (8.4%). Adverse drug reactions occurred in 3.7% of intervention neonates compared with 15.9% of controls, while 28-day readmission was 3.7% versus 13.1%, respectively. Hospitalization was shorter among intervention neonates, with 32.7% discharged within seven days compared with 3.7% of controls, while stays exceeding 14 days occurred in 11.2% and 42.1%, respectively. Stewardship processes also improved substantially. Guideline-concordant prescribing increased to 86.0%, blood cultures before therapy to 93.5%, appropriate dosing to 99.1%, therapy review at 48–72 hours to 81.3%, culture-guided therapy to 85.0%, and de-escalation to 84.1%. MDR organisms occurred in 16.8% of intervention cases compared with 40.2% of controls, while ESBL-producing organisms occurred in 7.5% versus 19.6%, respectively.
Conclusions: Antimicrobial stewardship interventions were associated with improved antimicrobial prescribing practices, reduced antimicrobial resistance indicators, and better neonatal clinical outcomes. Structured stewardship programs should therefore be strengthened and institutionalized within neonatal units in Kenya.

Keywords

Antimicrobial stewardship, neonatal sepsis, antimicrobial resistance, neonatal outcomes

Downloads

References

1. Ackers, L., Ackers-johnson, G., Seekles, M., Odur, J., & Opio, S. (2020). Opportunities and challenges for improving anti-microbial stewardship in low- and middle-income countries; lessons learnt from the maternal sepsis intervention in western Uganda. Antibiotics, 9(6), 1–16. https://doi.org/10.3390/antibiotics9060315 [Google Scholar] [Crossref]

2. Ahmed, S. K., Hussein, S., Qurbani, K., Ibrahim, R. H., Fareeq, A., Mahmood, K. A., & Mohamed, M. G. (2024). Antimicrobial resistance: Impacts, challenges, and future prospects. Journal of Medicine, Surgery, and Public Health, 2(2), 100–108. https://doi.org/https://doi.org/10.1016/j.glmedi.2024.100081 [Google Scholar] [Crossref]

3. Aluvaala, J., Tuti, T., Ogola, M., Lim, C., Cavany, S., English, M., Mochache, D., Murila, F., Kimani, W., Chabi, D., Naibei, L., Vitalis, J., Ngoda, A., Shikanda, G. H., Bonface, N., Malangachi, R., Midecha, I., Muhavi, E., Soita, S., … Muigai, P. (2025). Situational analysis of antibiotic prescriptions in Kenyan neonatal units for antimicrobial stewardship: a retrospective longitudinal study. EClinicalMedicine, 82(10), 321–335. https://doi.org/10.1016/j.eclinm.2025.103156 [Google Scholar] [Crossref]

4. Mascarenhas, D., Ho, M. S. P., Ting, J., & Shah, P. S. (2024). Antimicrobial Stewardship Programs in Neonates: A Meta-Analysis. Pediatrics, 153(6), e2023065091. https://doi.org/10.1542/peds.2023-065091 [Google Scholar] [Crossref]

5. Poggi, C., & Dani, C. (2023). New Antimicrobials for the Treatment of Neonatal Sepsis Caused by Multi-Drug-Resistant Bacteria: A Systematic Review. Antibiotics (Basel, Switzerland), 12(6). https://doi.org/10.3390/antibiotics12060956 [Google Scholar] [Crossref]

6. Villanueva, P., Freyne, B., Hickey, L., Carr, J., & Bryant, P. A. (2021). Impact of an antimicrobial stewardship intervention in neonatal intensive care: Recommendations and implementation. Journal of Paediatrics and Child Health, 57(8), 1208–1214. https://doi.org/10.1111/jpc.15427 [Google Scholar] [Crossref]

7. World Health Organization. (2023). Antimicrobial resistance. World Health Organisation Library, 18(12), 564–645. https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance [Google Scholar] [Crossref]

8. Zhang, W., Wu, P., Chui, C. S. L., Lim, W. W., & Cowling, B. J. (2021). Sepsis-associated hospitalisations and antimicrobial use in Hong Kong. Epidemiology and Infection, 149(56), e231. https://doi.org/10.1017/S0950268821002193 [Google Scholar] [Crossref]

Metrics

Views & Downloads

Similar Articles